Moreover, their expression in the cohort of ER+ BC patients was substantial in terms of both frequency and degree, with significant associations with established clinicopathologic prognostic indicators, such as Ki‐67, PR, and perinodal fat invasion. The gene discussed is MKI67; the disease is breast cancer.